Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

Eli Lilly and Company (NYSE:LLY) is a leading medicine company which discovers, develops, manufactures, and markets products ...

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their waists compared with Novo Nordisk’s rival Wegovy. Barbara ...

The Bank of Namibia announced on Thursday that it has successfully migrated the Namibia Interbank Settlement System ...

A blockbuster antitrust trial featuring Meta kicked off in the US last week, with CEO Mark Zuckerberg taking the stand in court to defend the tech giant’s acquisitions of Instagram and WhatsApp over a ...